PCSK9 inhibition to reduce cardiovascular disease risk

Author:

Tavori Hagai,Giunzioni Ilaria,Fazio Sergio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference74 articles.

1. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.;Hunt;Circulation,2004

2. Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta.;Ellison;Am J Cardiol,2005

3. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.;Hebert;J Am Med Assoc,1997

4. Christopher P Cannon on behalf of the IMPROVE IT Investigators1 CD, Brigham and Womens Hosp. IMPROVE-IT trial: a comparison of ezetimibesimvastatin versus simvastatin monotherapy on cardiovascular outcomes after acute coronary syndrome.;Boston;Circulation,2014

5. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.;Avis;J Am Coll Cardiol,2010

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3